Phoenix Biotech Acquisition Corp
NASDAQ:CERO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Phoenix Biotech Acquisition Corp
Free Cash Flow
Phoenix Biotech Acquisition Corp
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Phoenix Biotech Acquisition Corp
NASDAQ:CERO
|
Free Cash Flow
-$12.9m
|
CAGR 3-Years
-165%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
WP Carey Inc
NYSE:WPC
|
Free Cash Flow
-$566.2m
|
CAGR 3-Years
-32%
|
CAGR 5-Years
-56%
|
CAGR 10-Years
-11%
|
|
|
AltC Acquisition Corp
NYSE:OKLO
|
Free Cash Flow
-$115.4m
|
CAGR 3-Years
-125%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Annaly Capital Management Inc
NYSE:NLY
|
Free Cash Flow
-$189.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Ares Capital Corp
NASDAQ:ARCC
|
Free Cash Flow
-$1.7B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
N/A
|
|
|
SoFi Technologies Inc
NASDAQ:SOFI
|
Free Cash Flow
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Phoenix Biotech Acquisition Corp
Glance View
Phoenix Biotech Acquisition Corp. operates as a blank check company. The company is headquartered in Philadelphia, Pennsylvania. The company went IPO on 2021-10-06. The firm is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The firm has not selected any specific business combination target and has not, nor has anyone on its behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. The company intends to focus its search on the healthcare or healthcare related industries in the United States and Europe. The firm has not commenced any operations nor generated any revenues.
See Also
What is Phoenix Biotech Acquisition Corp's Free Cash Flow?
Free Cash Flow
-12.9m
USD
Based on the financial report for Dec 31, 2024, Phoenix Biotech Acquisition Corp's Free Cash Flow amounts to -12.9m USD.
What is Phoenix Biotech Acquisition Corp's Free Cash Flow growth rate?
Free Cash Flow CAGR 3Y
-165%
Over the last year, the Free Cash Flow growth was -748%. The average annual Free Cash Flow growth rates for Phoenix Biotech Acquisition Corp have been -165% over the past three years .
